| Name | Title | Contact Details |
|---|
OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.
Prevea Health Network is a Green Bay, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Springtide offers family-centered, collaborative care for children with developmental delays and disabilities. We are passionate about helping children grow and develop through evidence-based treatment, experienced therapists, and technology-enabled interdisciplinary clinics
Derma Sciences, Inc. (Derma Sciences) engages in the manufacture, marketing, and sale of three dermatological related product lines: wound care, wound closure, and specialty securement devices and skin care.
Health Sun is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.